How Recent Data Impacts Pancreatic Cancer Management

Integrity CE

M. Pishvaian

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Cancer Screening Molecular Tools

Fengting Yan

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Integrity CE

L. Zheng

mRNA Vaccine in Treatment of Pancreatic Cancer

Houston Methodist

J. Gonzalez

Updates in Perioperative Therapy of Pancreatic Cancer

Horizon CME

P. Philip

ESMO 2024 Summary: Updates in Pancreatic Cancer and Impacts on Pract…

2024 ESMO Annual Meeting Insights Hub

H. Babiker

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinical Ut…

2024 ASCO® Annual Meeting Insights Hub

S. Cohen

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Integrity CE

W. Burns

Targeting KRAS in Pancreatic Cancer

Harshabad Singh

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

ESMO 2024 Summary: Latest Advances in Targeted Therapies for Pancrea…

2024 ESMO Annual Meeting Insights Hub

D. Melisi

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Total Health

A. Grothey

How I Manage Immune Adverse Events in Solid Tumors

Balazs Halmos

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Horizon CME

A. Scott

UChicago Medicine Best of ASCO® 2024: Upper GI & Pancreatic Cancers

UChicago Medicine Annual Practice Updates in Hematology and Oncology

M. Amin